We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RHBBANK:MYXRHB Bank Bhd. Analysis

Data as of 2026-06-12 - not real-time

MYR 8.38

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

RHB Bank is trading at MYR 8.38, comfortably above its 20‑day (8.32) and 50‑day (8.26) SMAs and also above the 200‑day SMA (7.65), confirming a bullish price bias. The MACD histogram remains positive and the RSI sits at 54, indicating momentum is intact but not yet overbought. With a low beta of 0.16 and 30‑day volatility of roughly 12%, the stock shows limited market‑wide risk while still offering an estimated upside of about 7.7% toward the 8.60 resistance level. Valuation metrics reinforce the case: a trailing PE of 10.6 versus an industry average of 16.6, a PB of 1.1 and a dividend yield near 6% with a 63% payout ratio suggest the shares are priced on the cheap side of the sector.
Fundamentally, RHB Bank delivers solid profitability (ROE 10.6%, profit margin ≈ 40%) and a strong cash base (≈ MYR 19.7 bn) despite a recent negative operating cash flow. The newly announced RM1 bn SME financing partnership and anticipated net‑interest‑margin improvement for FY26 provide clear growth catalysts, while cost‑reduction initiatives are expected to lift earnings further. These drivers, combined with the attractive dividend and relative valuation, position the stock as a compelling buy for investors seeking both income and modest capital appreciation.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical alignment with price above key SMAs and positive MACD
  • Undervalued valuation relative to industry peers
  • High dividend yield offering immediate income

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Projected net‑interest‑margin expansion and cost‑reduction tailwinds
  • Sustained dividend payout and solid ROE
  • Strategic SME financing partnership expanding loan book

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable dividend profile with attractive yield
  • Valuation cushion but exposure to banking cycle and regulatory changes
  • Strong balance‑sheet liquidity offsetting operating cash‑flow weakness

Key Metrics & Analysis

Financial Health

Revenue Growth8.40%
Profit Margin39.78%
P/E Ratio10.6
ROE10.63%
ROA0.97%
P/B Ratio1.1
Op. Cash FlowMYR-11058659328
Industry P/E16.6

Technical Analysis

TrendBullish
RSI54.3
SupportMYR 8.08
ResistanceMYR 8.60
MA 20MYR 8.32
MA 50MYR 8.26
MA 200MYR 7.65
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Target PriceMYR 9.03
Upside/Downside7.70%
GradeUndervalued
TypeBlend
Dividend Yield5.97%

Risk Assessment

Beta0.16
Volatility11.79%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.